Drugs / amogammadex sodium
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07595393 | Aug 2026 → Jun 2027 expected | curariform drugs toxicity | Amckaus PTY LTD. | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | amogammadex sodium | “Receive amogammadex sodium at the end of surgery to reverse the effects of the muscle relaxant” NCT07595393 ↗ |